Relocated in 2019 to the city’s Dupont Circle Historic District, Goodwin’s Washington, DC office is home to 160 lawyers representing clients in complex corporate, litigation and regulatory matters with a focus on the private equity, technology, life sciences and financial services industries. Lawyers in our Washington, DC office are also equally proficient in advising the innovators and the investors across the real estate and healthcare sectors.
Areas of emphasis for our Washington, DC team include consumer financial services litigation and investigations; Supreme Court and appellate litigation; investment management; intellectual property; antitrust, global trade, and privacy and cybersecurity matters; financings, fund formation, M&A, buyouts, growth equity deals and growth company representations; collaborations and licensing; and FDA regulatory and litigation matters. Our appellate litigation practice is particularly strong and boasts several U.S. Supreme Court wins in recent years.
Steps away from many regulatory agencies of the U.S. federal government and Capitol Hill, we have a bench of regulatory lawyers and advisors with specialized knowledge and experience in energy, environmental, anti-trust, insurance, securities/SEC, FDA, transportation, and foreign trade policy and regulations. We advise U.S. clients locally and nationally, as well as global clients pursuing interests in the U.S., on compliance matters and represent them in government relations before the Executive Branch and the U.S. Congress.
Goodwin’s Washington, DC office and its lawyers are frequently recognized with industry awards and accolades. Most recently, The American Lawyer ranked the office as the number one place in DC for summer associates to work, and The National Law Journal named Goodwin to its 2019 Appellate Hot List.
A Note About Coronavirus: To ensure the safety of all our colleagues, clients and visitors in Goodwin offices around the globe, the firm has adopted a visitor policy, which can be found here.